metoprolol has been researched along with Adenocarcinoma in 1 studies
Metoprolol: A selective adrenergic beta-1 blocking agent that is commonly used to treat ANGINA PECTORIS; HYPERTENSION; and CARDIAC ARRHYTHMIAS.
metoprolol : A propanolamine that is 1-(propan-2-ylamino)propan-2-ol substituted by a 4-(2-methoxyethyl)phenoxy group at position 1.
Adenocarcinoma: A malignant epithelial tumor with a glandular organization.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hillebrand, U | 1 |
| Lang, D | 1 |
| Telgmann, RG | 1 |
| Hagedorn, C | 1 |
| Reuter, S | 1 |
| Kliche, K | 1 |
| Stock, CM | 1 |
| Oberleithner, H | 1 |
| Pavenstädt, H | 1 |
| Büssemaker, E | 1 |
| Hausberg, M | 1 |
1 other study available for metoprolol and Adenocarcinoma
| Article | Year |
|---|---|
Nebivolol decreases endothelial cell stiffness via the estrogen receptor beta: a nano-imaging study.
Topics: Adenocarcinoma; Adrenergic beta-Antagonists; Antihypertensive Agents; Arginine; Benzopyrans; Breast | 2009 |